Cargando…

Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer

BACKGROUND: Stereotactic ablative radiotherapy (SABR) shows a remarkable local control of non-small cell lung cancer (NSCLC) metastases, partially as a result of host immune status. However, the predictors of immune cells for tumor response after SABR are unknown. To that effect, we investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chao, Hu, Qinyong, Hu, Kai, Su, Huichao, Shi, Fang, Kong, Li, Zhu, Hui, Yu, Jinming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458628/ https://www.ncbi.nlm.nih.gov/pubmed/30971280 http://dx.doi.org/10.1186/s12967-019-1872-9

Ejemplares similares

Peripheral memory and naïve T cells in non-small cell lung cancer patients with lung metastases undergoing stereotactic body radiotherapy: predictors of early tumor response
por: Liu, Chao, et al.
Publicado: (2019)

Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer
por: Jung, Jinhong, et al.
Publicado: (2015)

Prognostic significance of peripheral CD8+CD28+ and CD8+CD28− T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy
por: Liu, Chao, et al.
Publicado: (2019)

Dosimetric Selection for Helical Tomotherapy Based Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer or Lung Metastases
por: Chi, Alexander, et al.
Publicado: (2012)

Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy
por: Lindsay, Adam D., et al.
Publicado: (2018)

Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases
por: Gutiérrez, Enrique, et al.
Publicado: (2021)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

Smoking history influences the prognostic value of peripheral naïve CD4+ T cells in advanced non-small cell lung cancer
por: Liu, Chao, et al.
Publicado: (2019)

Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer
por: Kaul, David, et al.
Publicado: (2015)

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
por: Chen, Hanbo, et al.
Publicado: (2018)

Peripheral blood lymphocyte changes after stereotactic ablative body radiotherapy to lung or liver metastases in patients with oligometastatic cancers
por: Novikov, Sergey Nikolaevich, et al.
Publicado: (2023)

Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
por: Goldsmith, Christy, et al.
Publicado: (2012)

Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience
por: Yahya, Sundus, et al.
Publicado: (2018)

Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer
por: Wang, Bin, et al.
Publicado: (2022)

Feasibility of Proton Transmission-Beam Stereotactic Ablative Radiotherapy versus Photon Stereotactic Ablative Radiotherapy for Lung Tumors: A Dosimetric and Feasibility Study
por: Mou, Benjamin, et al.
Publicado: (2014)

Proton-Based Stereotactic Ablative Radiotherapy in Early-Stage Non-Small-Cell Lung Cancer
por: Grant, Jonathan D., et al.
Publicado: (2014)

Frameless stereotactic body radiation therapy for multiple lung metastases
por: Li, Qilin, et al.
Publicado: (2014)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience
por: Ricco, Anthony, et al.
Publicado: (2017)

High proportion of circulating CD8 + CD28- senescent T cells is an independent predictor of distant metastasis in nasopharyngeal canrcinoma after radiotherapy
por: Xu, Xiaotian, et al.
Publicado: (2023)

Stereotactic ablative body radiotherapy versus conventionally fractionated radiotherapy for early stage large cell neuroendocrine carcinoma of the lung
por: Wegner, Rodney E, et al.
Publicado: (2020)

Quantification of interplay and gradient effects for lung stereotactic ablative radiotherapy (SABR) treatments
por: Tyler, Madelaine K.
Publicado: (2016)

Migration of implanted markers for image‐guided lung tumor stereotactic ablative radiotherapy
por: Hong, Julian C., et al.
Publicado: (2013)

Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report
por: Yeo, Seung-Gu
Publicado: (2017)

Is lung stereotactic ablative radiotherapy safe after pneumonectomy?—a systematic review
por: Arifin, Andrew J., et al.
Publicado: (2020)

Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases
por: van Sörnsen de Koste, John R., et al.
Publicado: (2021)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

CD43 is a murine T cell costimulatory receptor that functions independently of CD28
Publicado: (1995)

Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer
por: Oweida, Ayman, et al.
Publicado: (2017)

Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2023)

Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer
por: Benzaquen, Jonathan, et al.
Publicado: (2023)

Detection of second primary lung cancers on surveillance imaging following stereotactic ablative radiotherapy for non-small cell lung cancer
por: Aldin, Muhtada Kamal, et al.
Publicado: (2022)

Effectiveness of temozolomide combined with whole brain radiotherapy for non‐small cell lung cancer brain metastases
por: Zhu, Ying, et al.
Publicado: (2018)

Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study
por: Aoki, Masahiko, et al.
Publicado: (2016)

Efficacy and tolerability of stereotactic body radiotherapy for lung metastases in three patients with pediatric malignancies
por: Deck, Jared, et al.
Publicado: (2019)

Stereotactic radiotherapy for brain metastases in patients with lung cancer; outcome and toxicity in clinical practice
por: Gunnarsson, Kerstin, et al.
Publicado: (2022)

CD28(−) and CD28(low)CD8(+) Regulatory T Cells: Of Mice and Men
por: Vuddamalay, Yirajen, et al.
Publicado: (2017)

Association of Twice-Daily Radiotherapy With Subsequent Brain Metastases in Adults With Small Cell Lung Cancer
por: Zeng, Haiyan, et al.
Publicado: (2019)

Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy
por: Stauder, Michael C, et al.
Publicado: (2013)

Intractable Pleural Effusion After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Katano, Atsuto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6vdo0hfsces0giq3l4o5pgsepi